PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology.

Autor: Eastwood SM; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Meyer MR; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Kirmess KM; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Wente-Roth TL; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Irvin F; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Holubasch MS; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Verghese PB; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., West T; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Braunstein JB; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Yarasheski KE; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA., Contois JH; C2N Diagnostics, 4340 Duncan Avenue, Suite 110, Saint Louis, MO 63110, USA.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Aug 10; Vol. 14 (16). Date of Electronic Publication: 2024 Aug 10.